1. Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma
   Jianwen Jiang et al, 2020, Aging CrossRef
2. ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
   Jun Hou et al, 2022, Frontiers in Pharmacology CrossRef
3. Low expression of acyl-CoA thioesterase 13 is associated with poor prognosis in ovarian serous cystadenocarcinoma
   Xiaofeng Lv et al, 2023, Frontiers in Genetics CrossRef
4. GRP94 Is Involved in the Lipid Phenotype of Brain Metastatic Cells
   Naiara Santana-Codina et al, 2019, International Journal of Molecular Sciences CrossRef
5. Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
   Tao Zhang et al, 2021, Frontiers in Oncology CrossRef
6. A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity
   null Santos et al, 2019, Genes CrossRef
7. Increased Risk of High Body Fat and Altered Lipid Metabolism Associated to Suboptimal Consumption of Vitamin A Is Modulated by Genetic Variants rs5888 (SCARB1), rs1800629 (UCP1) and rs659366 (UCP2)
   Sebastià Galmés et al, 2020, Nutrients CrossRef
8. The BRD4-SRPK2-SRSF2 signal modulates the splicing efficiency of ACSL3 pre-mRNA and influences erastin-induced ferroptosis in osteosarcoma cells
   Shun-Hong Luo et al, 2023, Cell Death & Disease CrossRef
9. Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic
   Adrián Bouzas et al, 2022, Frontiers in Oncology CrossRef